Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: Results of four randomized trials

Breast Cancer Research and Treatment

Volumn 128, Issue 3, 2011, Pages 625-631

  Zhou, Wen Bin ^a   Ding, Qiang ^a   Chen, Ling ^a   Liu, Xiao An ^a   Wang, Shui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Efficacy; Meta analysis; Side effects; Tamoxifen; Toremifene

Indexed keywords

TAMOXIFEN; TOREMIFENE;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; GYNECOLOGIC DISEASE; HOT FLUSH; HUMAN; LUNG EMBOLISM; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SURVIVAL RATE; SWEATING; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; TAMOXIFEN; TOREMIFENE; TREATMENT OUTCOME;

EID: 79960842378     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1556-5     Document Type: Review

References (25)

1. CK Osborne 1998 Tamoxifen in the treatment of breast cancer N Engl J Med 339 22 1609 1618 10.1056/NEJM199811263392207 9828250 10.1056/NEJM199811263392207 1:CAS:528:DyaK1cXnvFOitLs%3D (Pubitemid 28536137)
2. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
3. JF Forbes J Cuzick A Buzdar A Howell JS Tobias M Baum 2008 Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Lancet Oncol 9 1 45 53 10.1016/S1470- 2045(07)70385-6 18083636 10.1016/S1470-2045(07)70385-6
4. AS Coates A Keshaviah B Thurlimann H Mouridsen L Mauriac JF Forbes R Paridaens M Castiglione-Gertsch RD Gelber M Colleoni I Lang L Del Mastro I Smith J Chirgwin JM Nogaret T Pienkowski A Wardley EH Jakobsen KN Price A Goldhirsch 2007 Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 J Clin Oncol 25 5 486 492 10.1200/JCO.2006.08.8617 17200148 10.1200/JCO.2006.08.8617 1:CAS:528:DC%2BD2sXivF2mt7Y%3D (Pubitemid 350002953)
5. EP Winer C Hudis HJ Burstein RT Chlebowski JN Ingle SB Edge EP Mamounas J Gralow LJ Goldstein KI Pritchard S Braun MA Cobleigh AS Langer J Perotti TJ Powles TJ Whelan GP Browman 2002 American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002 J Clin Oncol 20 15 3317 3327 12149306 10.1200/JCO.2002.06.020 1:CAS:528: DC%2BD38XmsF2rs70%3D (Pubitemid 34831529)
6. S Kallio L Kangas G Blanco R Johansson A Karjalainen M Perila I Pippo H Sundquist M Sodervall R Toivola 1986 A new triphenylethylene compound, Fc-1157a. I. Hormonal effects Cancer Chemother Pharmacol 17 2 103 108 2941176 10.1007/BF00306736 1:CAS:528:DyaL28XltVyrtLg%3D (Pubitemid 16082005)
7. S Pyrhonen J Ellmen J Vuorinen M Gershanovich T Tominaga M Kaufmann DF Hayes 1999 Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer Breast Cancer Res Treat 56 2 133 143 10573106 10.1023/A: 1006250213357 1:CAS:528:DyaK1MXnvVKitr4%3D (Pubitemid 29494831)
8. K Holli R Valavaara G Blanco V Kataja P Hietanen M Flander E Pukkala H Joensuu 2000 Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer Finnish Breast Cancer Group J Clin Oncol 18 20 3487 3494 11032589 1:CAS:528:DC%2BD3cXnvV2kurw%3D
9. O Pagani S Gelber K Price D Zahrieh R Gelber E Simoncini M Castiglione-Gertsch AS Coates A Goldhirsch 2004 Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93 Ann Oncol 15 12 1749 1759 10.1093/annonc/mdh463 15550579 10.1093/annonc/mdh463 (Pubitemid 40012241)
10. JD Lewis AB Chagpar EA Shaughnessy J Nurko K McMasters MJ Edwards 2010 Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer Cancer 116 10 2307 2315 10.1002/cncr.24940 20209619 1:CAS:528: DC%2BC3cXmsFyqsrk%3D
11. P Hirsimaki A Aaltonen E Mantyla 2002 Toxicity of antiestrogens Breast J 8 2 92 96 11896754 10.1046/j.1524-4741.2002.08204.x 1:CAS:528: DC%2BD38XjtVGntLs%3D (Pubitemid 34233587)
12. X Liu Z Wang J Yu G Lei S Wang 2010 Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis Breast Cancer Res Treat 124 3 821 825 10.1007/s10549-010-0910-3 20437198 10.1007/s10549-010- 0910-3 1:CAS:528:DC%2BC3cXhtlyrsrnM
13. MJ Bradburn JJ Deeks JA Berlin A Russell Localio 2007 Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events Stat Med 26 1 53 77 10.1002/sim.2528 16596572 10.1002/sim.2528 (Pubitemid 46099417)
14. LA Smith VR Cornelius CJ Plummer G Levitt M Verrill P Canney A Jones 2010 Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials BMC Cancer 10 337 10.1186/1471-2407-10-337 20587042 10.1186/1471-2407-10-337
15. J Lau JP Ioannidis CH Schmid 1997 Quantitative synthesis in systematic reviews Ann Intern Med 127 9 820 826 9382404 1:STN:280:DyaK1c%2FgtVOmuw%3D%3D (Pubitemid 27465551)
16. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 3 177 188 3802833 10.1016/0197-2456(86)90046-2 1:STN:280: DyaL2s7gsVamtA%3D%3D (Pubitemid 17189972)
17. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 4 719 748 13655060 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D
18. MP Goetz SK Knox VJ Suman JM Rae SL Safgren MM Ames DW Visscher C Reynolds FJ Couch WL Lingle RM Weinshilboum EG Fritcher AM Nibbe Z Desta A Nguyen DA Flockhart EA Perez JN Ingle 2007 The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen Breast Cancer Res Treat 101 1 113 121 10.1007/s10549-006-9428-0 17115111 10.1007/s10549-006-9428-0 1:CAS:528:DC%2BD2sXisVylsg%3D%3D (Pubitemid 47555336)
19. M Ingelman-Sundberg 2005 Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity Pharmacogenomics J 5 1 6 13 10.1038/sj.tpj.6500285 15492763 10.1038/sj.tpj. 6500285 1:CAS:528:DC%2BD2MXivFKntQ%3D%3D (Pubitemid 40220611)
20. R Carpenter 2008 Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen Eur J Surg Oncol 34 7 746 755 10.1016/j.ejso.2008.01.011 18296017 1:STN:280:DC%2BD1czovVyguw%3D%3D
21. T Saarto C Blomqvist C Ehnholm MR Taskinen I Elomaa 1996 Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer J Clin Oncol 14 2 429 433 8636753 1:CAS:528:DyaK28XhsV2lsb0%3D (Pubitemid 26051003)
22. S Shibutani A Ravindernath I Terashima N Suzuki YR Laxmi Y Kanno M Suzuki TI Apak JJ Sheng MW Duffel 2001 Mechanism of lower genotoxicity of toremifene compared with tamoxifen Cancer Res 61 10 3925 3931 11358807 1:CAS:528: DC%2BD3MXktVWqsL0%3D (Pubitemid 32720952)
23. S Shibutani A Ravindernath N Suzuki I Terashima SM Sugarman AP Grollman ML Pearl 2000 Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen Carcinogenesis 21 8 1461 1467 10910945 10.1093/carcin/21.8.1461 1:CAS:528:DC%2BD3cXlvVeqs7c%3D (Pubitemid 30601641)
24. HD Homesley I Shemano RA Gams DS Harry PG Hickox RW Rebar RC Bump TJ Mullin AC Wentz RV O'Toole, et al. 1993 Antiestrogenic potency of toremifene and tamoxifen in postmenopausal women Am J Clin Oncol 16 2 117 122 8452102 10.1097/00000421-199304000-00007 1:STN:280:DyaK3s7pvVygtg%3D%3D (Pubitemid 23109718)
25. E di Salle T Zaccheo G Ornati 1990 Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat J Steroid Biochem 36 3 203 206 2142233 10.1016/0022-4731(90)90005-D 1:CAS:528:DyaK3cXlt1Grur4%3D (Pubitemid 20222768)